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Abstract
Objective—Multilevel models have become a standard data analysis approach in intervention
research. Although the vast majority of intervention studies involve multiple outcome measures,
few studies use multivariate analysis methods. The authors discuss multivariate extensions to the
multilevel model that can be used by psychotherapy researchers.
Method and Results—Using simulated longitudinal treatment data, the authors show how
multivariate models extend common univariate growth models and how the multivariate model
can be used to examine multivariate hypotheses involving fixed effects (e.g., does the size of the
treatment effect differ across outcomes?) and random effects (e.g., is change in one outcome
related to change in the other?). An online supplemental appendix provides annotated computer
code and simulated example data for implementing a multivariate model.
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Conclusions—Multivariate multilevel models are flexible, powerful models that can enhance
clinical research.
Keywords
intervention data; multilevel; multivariate
Analyzing Multiple Outcomes in Clinical Research Using Multivariate Multilevel Models
Multilevel (mixed) models (Hox, 2010; Raudenbush & Bryk, 2002) have become a standard
method for analyzing psychotherapy outcome data given the hierarchical structure of
psychotherapy data, for example: (a) observations (level-1) clustered within persons
(level-2) in longitudinal data (Singer & Willet, 2003), (b) patients (level-1) clustered within
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therapists or groups (level-2; Crits-Christoph & Mintz, 1991; Wampold & Serlin, 2000), and
(c) effect sizes (level-1) clustered within studies (level-2) in meta-analysis (Hox, 2010).
Moreover, it is not unusual to have additional grouping factors that can lead to three or more
levels within psychotherapy data (e.g., repeated measures on individuals nested within
couples; Atkins, 2005).
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The hierarchical structure of psychotherapy data is important for both substantive and
methodological reasons. Substantively, we are often interested in variability among higherlevel factors, such as person-to-person variability or therapist-to-therapist variability
(Baldwin & Imel, 2013; Crits-Christoph et al., 1991; Imel, Baldwin, Bonus, & Maccoon,
2008; Saxon & Barkham, 2012). Methodologically, the hierarchical structure leads to
correlations among the observations within a cluster. For example, in group therapy, data
from patients within the same group are likely to be correlated relative to data from patients
in other groups. This correlation violates the assumption of independence of observations
common to most statistical tests, which can lead to biased p-values, incorrect confidence
intervals, and inflated effect sizes (Baldwin, Murray, & Shadish, 2005; Crits-Christoph &
Mintz, 1991; Wampold & Serlin, 2000). Multilevel models accommodate the correlation
among observations by modeling between-cluster variability via additional error terms
called random effects (Raudenbush & Bryk, 2002; Singer & Willet, 2003) and are also more
flexible regarding ignorable missing data and the correlation structure of the residuals than
earlier methods (e.g., ANOVA; Singer & Willet, 2003). In addition, multilevel models can
accommodate longitudinal data where participants are measured on different schedules
(Hox, 2010), treat time as categorical, continuous, or some combination (Singer & Willet,
2003), be extended to situations where clustering affects some participants but not others
(Baldwin, Bauer, Stice, & Rohde, 2011; Bauer, Sterba, & Hallfors, 2008), and accommodate
non-normal outcomes (Rabe-Hesketh & Skrondal, 2008). Overall, multilevel models
represent highly useful statistical tools for psychotherapy researchers.
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However, one particular class of multilevel models has not been widely adopted within the
psychotherapy research community—multivariate multilevel models, which extend
multilevel models to two or more outcomes (Hox, 2010; MacCallum, Kim, Malarkey, &
Kiecolt-Glaser, 1997).1 It is unusual to find psychotherapy research studies that only involve
a single outcome variable. However, few researchers employ multivariate techniques when
evaluating multiple outcomes, especially when multilevel models were used to analyze
outcomes. As we will show, this omission results in a failure to test important theoretical
questions that are best examined in the multivariate, multilevel context.
Historically, psychotherapy researchers regularly used multivariate data analysis methods,
such as MANOVA, to control the experiment-wise Type I error rates. For example, a
common strategy was to test for a treatment effect across outcomes using MANOVA and
follow-up with series of ANOVA analyses on each outcome. Thus, even when MANOVA
was used, the fundamental focus of the analysis was on univariate hypotheses. However,
multivariate models can be used to address multivariate hypotheses. Examples of

1Occasionally, the term multivariate is used to refer to models with a single outcome variable but with multiple predictor variables. In
this paper, we use the term multivariate to refer to models with two or more outcome variables.
J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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multivariate hypotheses include testing whether outcomes have different average rates of
change (Kaysen et al., 2011) or whether change in one outcome is related to change in
another (Suvak, Walling, Iverson, Taft, & Resick, 2009).
The present paper introduces multivariate multilevel models for intervention research and
illustrates how to fit and interpret the models. Example data throughout focuses on
examining relationships between primary and secondary outcomes in a randomized trial. We
examine whether predictor variables (e.g., treatment condition) have different relationships
across outcomes and model relationships between outcomes (e.g., how is change in one
outcome related to change in another). Although a brief overview of univariate multilevel
models included as a bridge for to multivariate models, we assume that readers have a basic
familiarity with univariate multilevel models. Readers desiring a more in-depth discussion
of univariate models can consult a number of excellent textbooks (Gelman & Hill, 2007;
Raudenbush & Bryk, 2002; Singer & Willet, 2003). We have included an online appendix
that provides annotated code for fitting these models in Stata, SAS, SPSS, R, and Mplus.

Differential Fixed Effects Across Outcomes
NIH-PA Author Manuscript

Most intervention studies include multiple outcomes. For example, a study comparing
cognitive-behavioral therapy and acceptance and commitment therapy for depression may
include depression measures as well as quality of life measures, which could be classified as
primary (depression) or secondary (quality of life) outcomes. Researchers may be interested
in whether treatment effects differ by outcome type for both clinical and theoretical reasons.
Clinically, patients presenting for treatment of depression may be most keenly interested in
the impact of treatment on their depressive symptoms, though improvement in all areas of
their life would likely be welcome. Further, a cognitive-behavioral therapy that explicitly
targets depression symptoms might be expected to have an earlier and potentially larger
impact on these symptoms (i.e., quality of life might improve as a result of decreases in
depression). Theoretically, some have argued that larger treatment effects for primary
outcomes are consistent with the hypothesis that factors specific to a treatment package,
rather than factors common across treatment packages, are partially responsible for change
(Hofmann & Lohr, 2010).
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Most researchers do not directly test for differential treatment effects across outcomes, yet
they often interpret their results as if they had tested for differential effects. Indeed, in our
review work, we often find researchers invoking the “eyeball test” in such situations, noting
simply that effects for primary outcomes were “larger” than those for secondary outcomes.
Thus, results sections from clinical research usually involve using multilevel models, or a
similar analysis technique, to examine intervention effects one outcome at a time. Even if
the outcomes are grouped in primary and secondary categories, such grouping is usually for
the purposes of the written report rather than incorporated directly into the data analysis. The
results are then summarized with respect to which outcomes had significant treatment
effects and which did not. For example, McDonagh et al. (2005) randomized participants
meeting criteria for posttraumatic stress disorder (PTSD) to cognitive-behavioral therapy
(CBT), present centered therapy (PCT), and wait-list (WL). In the analysis, the authors
examined treatment effects across each outcome (using the group×time interaction in a
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repeated measures ANOVA and post-hoc tests). The authors found a statistically significant
intervention effect for PTSD symptoms but not for depression. The authors interpret the
statistical significance for one outcome but not the other as important: “The fact that this
treatment [PCT] had more of an impact on PTSD symptoms than on depressive symptoms
suggests its mechanism is not simply an antidepressant effect such as has already been
demonstrated for problem-solving therapy” (p. 522).
However, comparisons of intervention effects require a statistical test of the difference (cf.
Nieuwenhuis, Forstmann, & Wagenmakers, 2011). In other words, we need an explicit test
of whether the size of the intervention effect depends upon the outcome type—we need to
test the intervention effect by outcome interaction. The idea is similar to moderator analyses
in psychotherapy meta-analyses, in which one tests whether an effect size (i.e., treatment
effect) varies as a function of study characteristics.

NIH-PA Author Manuscript

To get a sense of how often researchers analyze multiple outcomes and do not investigate
whether treatment effects vary across outcomes, we reviewed randomized trials that used
multilevel models published in the Journal of Consulting and Clinical Psychology from
2009 to 2012. We coded whether the study included multiple outcomes and whether the
authors used multivariate methods to investigate differential treatment effects. We identified
60 randomized trials that used multilevel modeling to estimate treatment effects for multiple
outcomes. Of these 60, one tested for differential treatment effects across outcomes (Jouriles
et al., 2009), suggesting a profound mismatch between study design—with multiple
outcomes—and study analysis.
Extending the Univariate Multilevel Model

NIH-PA Author Manuscript

Testing multivariate hypotheses about fixed effects can be accomplished by extending
multilevel models to accommodate two or more outcomes. To illustrate the extension, we
simulated data to mimic a clinical trial comparing cognitive-behavioral therapy (CBT) to a
no-treatment control for the treatment of depression, three timepoints (baseline,
midtreatment, posttreatment), 100 participants (50 per condition), and two outcomes—
depression and quality of life. We coded time as 0, 1, and 2, with 0 representing the baseline
timepoint. We also coded treatment condition (Tx) as 1 for CBT and 0 for control. In the
population model, the treatment effect for depression was a .5 standard deviation difference
at posttreatment (time 2) between CBT and control and there was no treatment effect for
quality of life.
The univariate growth-curve models for each outcome can be written as follows (Singer &
Willet, 2003):
(1)

(2)

Focusing on Equation (1), y1ij is the depression outcome at time i for person j. β10 is the
overall intercept, and like all intercepts, it represents the expected depression value (i.e.,
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mean) of the outcome when all predictors are equal to 0, in this case when Timeij = 0
(Baseline) and Txj = 0 (control). Changing the coding method for time or treatment
condition (or by including other variables in the model) will alter the specific interpretation
of the intercept (see Singer and Willet, 2003, for a discussion of alternative methods for
coding time). β11 is the average rate of change in depression symptoms during treatment for
the control condition, β12 is the mean difference between CBT and control at baseline, β13 is
the difference in rate of change between CBT and control (i.e., the treatment effect), u1j is a
random effect representing person-specific differences at baseline (i.e., unique baseline
values for each participant), v1j is a random effect representing person-specific differences in
change during treatment (i.e., unique rate of change for each participant), and e1ij is residual
error. The parameters in Equation (2) have identical interpretations except they pertain to
quality of life.
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Because the data in our example are longitudinal, the repeated observations within an
individual are correlated. The random effects described above allow us to accommodate this
correlation. Specifically, the models in Equations (1) and (2) assume that observations are
independent conditional on the random effects (i.e., uncorrelated once the random effects are
taken into account) and that the random effects are normally distributed (Singer & Willet,
2003):
(3)

(4)

Focusing on Equation (3) the random effects for depression, u1j and v1j, come from a normal

NIH-PA Author Manuscript

distribution with a mean of 0, variances of
and , and a covariance of
. The
parameters in Equation (4) have identical interpretations except that they pertain to quality
of life. It may not be obvious at first glance, but Equations (3) and (4) encapsulate one of the
advantages of multilevel models. The models shown in Equations (1) and (2) model the
person-to-person variability in intercepts and slopes via random effects. However, multilevel
models accomplish this by assuming that these intercepts and slopes come from a
distribution of intercepts and slopes that are normally distributed. Thus, as opposed
estimating 100 distinct intercept and 100 distinct slopes to capture between person
heterogeneity in intercepts and slopes, multilevel models accomplish this by estimating two
variances and a covariance.2 The residual errors are also normally distributed, with unique
residual variances for each outcome:

2Note that the when using maximum likelihood methods to estimate these models, the random effects are not estimated. Rather, the
variance/covariance matrix of the random effects is estimated. The random effects can be predicted using empirical Bayes methods
(Raudenbush & Bryk, 2002).
J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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(6)

By fitting two independent models in Equations (1)–(6), we implicitly assume that
depression and quality of life are independent. This is untenable as two outcomes from the
same participant are almost certainly related. For example, change in depression is likely
correlated with change in quality of life; thus, we should estimate the covariance between
the random slopes (v1j and v2j). Further, because the outcomes are repeated measures on the
same person, there will likely be a relationship between the residual errors (Fieuws &
Verbeke, 2004). As discussed below, ignoring these relationships across outcomes will
cause problems for tests of the difference between treatment effects.
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A multivariate model can address these limitations because it allows us to model the
relationships between the variables via correlations amongst the random effects and amongst
the residuals (Hox, 2010; MacCallum et al., 1997). To help bridge the univariate and fully
multivariate model, we describe a form of the multivariate multilevel model that makes the
same assumptions as the two univariate models described above and is identical except that
both outcomes are model simultaneously rather than sequentially. We then show how the
assumptions inherent to the univariate models can be relaxed so that a fully multivariate
model can be estimated.
In the univariate models, we described the random effects as coming from two distinct
multivariate normal distributions described in Equations (3) and (4). In a multivariate model
—that is, a model that includes both depression and quality of life simultaneously—the
random effects are drawn from a single multivariate normal distribution (Snijders & Bosker,
2012). A multivariate normal distribution consistent with Equations (3) and (4) can be
expressed as follows:
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(7)

The covariance matrix for the random effects in Equation (7), ΩG, contains the same four
variance components and the same two covariances as in Equations (3) and (4). However,
Equation (7) makes explicit that we assume no relationship among the random effects across
outcomes by constraining the between-outcome covariances to 0. For example, the
covariance in the third row and first column is fixed to 0 and represents the covariance
between the random intercept for depression and the random intercept for quality of life.
Like the random effects, the multivariate model assumes the residuals come from a single
multivariate normal distribution rather than two univariate normal distributions (Snijders &
Bosker, 2012). A multivariate normal representation of Equations (5) and (6) is:

J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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We refer to a multivariate model the estimates the growth models in Equations (1) and (2)
and covariance matrices described in Equations (7) and (8) as the multivariate independent
outcomes model. The independent outcomes model is simply a multivariate version of our
earlier univariate models that we use as a baseline to compare multivariate models that allow
a relationship between the outcomes.
As noted previously, the problem with the independent outcomes model is that it assumes
that depression and quality of life are unrelated. If we are interested in testing parameters
that are fundamentally multivariate, the independence model will lead to problems. For
example, if our goal was to understand whether CBT had a stronger effect relative to no
treatment on depression than on quality of life (i.e., a parameter that involves multiple
outcomes), then the independence model will produce an incorrect hypothesis test and
confidence interval, as we show below.

NIH-PA Author Manuscript

A multivariate model that estimates the relationships between random effects across
outcomes and residuals across outcomes will produce appropriate estimates and standard
errors for multivariate parameters. We call this type of model a multivariate related
outcomes model. In the related outcomes model, all covariances between each random effect
are estimated:

(9)
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Thus, we now estimate the covariance between any combination of random intercepts and
slopes—we no longer constrain the between-outcome covariances to 0 as we did in Equation
(7). For example, the covariance between the random slopes, which describes the covariance
between the rate of change in depression and quality of life, is σv1v2. The related outcomes
model also estimates a covariance among the residual errors rather than constraining the
covariance to 0 as we did in Equation (8):
(10)

The only difference between the independent outcomes and related outcomes models are the
covariances among the random effects across outcomes and the covariance among the
residuals. These covariances can be important because they (a) can be interpreted
substantively (e.g., what is the correlation between intercepts and slopes across the two
outcomes?) and (b) impact statistical tests for multivariate parameters.

J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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Before turning to the application and results of the multivariate multilevel models, we
briefly comment on data set-up. Multilevel modeling software developed from a structural
equation model framework (e.g., Mplus) will typically expect the data to be in the wide
format shown in Table 1. Consequently, multiple equations much like those represented
above in Equations (1), (2), (9), and (10) can be specified. However, for most multilevel
software packages (e.g., xtmixed in Stata, PROC MIXED in SAS, lme4 in R), we must
combine Equations (1) and (2) into a single equation using a set of indicator variables to
define which observations go with depression and quality of life. The long dataset in Table 1
provides an example of how the data must be organized for a single equation model. The
values for depression and quality of life are combined into a single outcome variable, yhij,
where h indexes the outcome measure. We also create two indicator variables, dj and qj,
where dj = 1 for depression and 0 for quality of life and qj = 1 for quality of life and 0 for
depression. (Connecting the symbols to the actual column names in Table 1: yhij = Y, dj =
Depression, and qj = Quality of Life.) We then combine Equations (1) and (2) with the
indicator variables to produce a single equation:
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(11)

The random effects (u1j, u2j, v1j, and v2j) and residual errors (e1ij and e2ij) are distributed as
in Equations (9) and (10), respectively.
We can verify that Equation (11) is identical to Equations (1) and (2) by examining the
value of yhij when plugging in the appropriate values of dj and qj for depression and quality
of life. The value of yhij for the depression outcome is:
(12)

Likewise, the value of yhij for quality of life is:
(13)
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Differential Treatment Effects
Using the simulated treatment data, we examined the differential treatment effects of CBT
versus control on depression and quality of life. The online appendix material provides the
data and annotated syntax for estimating these models in Stata, SPSS, SAS, Mplus, and R.
We report the output from xtmixed in Stata using maximum likelihood estimation, although
the software packages provide identical results out to 4 to 5 decimals places. In this section,
we first compare the results and fit of the univariate, multivariate independent outcomes, and
multivariate related outcomes models so that we can compare the results of each model.
Second, we show how to test for differential treatment effects using a post analysis contrast
and how the standard error for this contrast differs across the multivariate independent

J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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outcomes and multivariate related outcomes models. Third, we describe two methods in
addition to the post analysis contrast for testing differential treatment effects. Finally, testing
differential treatment effects across outcomes requires that the outcomes be on the same
metric. We discuss why outcomes need to be on the same metric and how one can use
standardized scores in situations where outcomes are on different metrics and one wants to
test differential effects.
Table 2 provides the estimates and standard errors for the fixed effects, the variance and
covariance estimates for the random effects and residuals, and the deviance for each model.
Table 2 makes clear that the independent outcomes model is identical to the two univariate
models put together. The independent outcomes model estimates all the parameters in the
two univariate models. Furthermore, the deviance, a measure of model fit (Singer & Willet,
2003), of the independent outcomes model is the sum of the deviance of the two univariate
models. Thus, we can use the independent outcomes model as a comparison to investigate
whether the multivariate related outcomes model improves upon the univariate models
typically used in clinical research.
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Because the independent outcomes model is nested within the related outcomes model, we
can test whether the addition of the covariances among outcomes in the random effects and
residuals significantly improves fit using a likelihood ratio test. The independent outcomes
model is considered nested within the related outcomes model because the independent
outcomes model (a) uses the same data as the related outcomes model and (b) is a
constrained version of the related outcomes model (i.e., the between-outcome covariances
are constrained to zero). The likelihood ratio test compares the difference between the
deviances of the models (1501.63 − 1444.80 = 56.83; smaller is better) to a χ2-distribution
with degrees of freedom equal to the difference in the number of parameters between
models (21 − 16 = 5). There are five additional parameters as the related outcomes model
includes four additional covariances in the random effects of intercepts and slopes, and also
allows the residual errors to be correlated. The likelihood ratio test equals χ2(5)=56.83, p<.
001, which indicates that the related outcomes model fits the data better than the
independent outcomes model. This test is also a joint test of the significance for the
additional covariance parameters in the related outcomes model.

NIH-PA Author Manuscript

Although the related outcomes model has the best fit, Table 2 indicates that the parameter
estimates do not change from independent model to fully multivariate model. Thus, it is
reasonable to ask why should we bother with the multivariate model? All parameter
estimates in Table 2, except for the covariances among the random effects between
outcomes and covariance among residuals between outcomes, are univariate parameters—
only data from one of the outcomes contributes to the univariate estimates. Consequently,
the estimates and standard errors, for both the fixed effects and variance/covariances, are
identical across models. In some cases, some parameters are not estimated and thus assumed
zero but that does not affect the estimates of the univariate parameters. However, when we
consider multivariate parameters, the differences between the independent outcomes and
related outcomes models is important.

J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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The additional covariances will affect tests of whether the treatment effects differ across
outcomes. First, consider the univariate treatment effects for depression and quality of life,
which are the two time×treatment interactions terms, β13 and β23. Each coefficient describes
the difference in rate of change among the intervention conditions for each outcome
separately, with the null hypothesis being that there is no difference between conditions. The
time×treatment interaction for depression was β13=−.41 (p < .05, 95% CI = −.60, −.22)
whereas the time×treatment interaction for quality of life was β23=−.09 (p = .41, 95% CI =
−.30, .12). Thus, we reject the null hypothesis of no treatment effect for depression but not
for quality of life. We may be tempted to also conclude that the effects of treatment versus
control are larger for depression than quality of life. However, this would be incorrect
because we have only tested the univariate null hypothesis that each coefficient is zero. We
have not tested whether the coefficients differ from one another—that is, we have not tested
the multivariate null hypothesis that β13 − β23=0.
To test the null hypothesis that β13 − β23=0 we can use a post-analysis contrast. A common
form for this test is:
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(14)

where the denominator is the standard error of the difference between treatment effects,
and
are the expected variability of the treatment effect across samples and σβ13β23 is the
covariance between the treatment effects across samples.3 As we have seen, the independent
outcomes and related outcomes models will provide identical estimates of β13 and β23, so the
numerator in Equation (14) will be identical across models. Thus, the key part of Equation
(14) is the standard error, specifically the covariance, σβ13β23. If depression and quality of
life are correlated, then independent outcomes misspecifies the relationships among the
random effects and among the residuals and σβ13β23 will incorrectly be set to 0. In contrast,
the related outcomes model correctly specifies the relationships among the random effects
and residuals and σβ13β23 will be positive. The misspecification in the independent outcomes
model means the standard error will be too large and will thus reduce power.
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The test of differential treatment effects was significant in both the independent outcomes
(β13 − β23=−0.32, se = 0.15, z = −2.23, p = 0.03) and related outcomes model (β13 − β23=
−0.32, se = 0.10, z = −3.14, p = 0.002). Note, however, that the standard error in the
independent outcomes model was 50% larger than in the related outcomes model because
the independent outcomes model does not take into account the correlation among the
outcomes. To provide a sense of how the larger standard error will impact power, we
simulated 10,000 additional datasets using the population parameters described above and fit
the independent and related outcomes models to each dataset. To assess power, we
computed how often the test of the differential treatment effects was significant across the
10,000 datasets. Power was 0.81 for the related outcomes model and 0.68 for the
independent outcomes model, a 16% decrease in power.
3These variances and covariances are part of the asymptotic variance/covariance matrix of the fixed effects. See the online appendix
for instructions how to request this information within statistical packages.
J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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Equation (14) is not the only method for evaluating differential intervention effects. A
second method is to use a likelihood ratio test to compare the fit of a model that estimates
distinct treatment effects by outcome such as Equation (11) to a model that estimates a
common treatment effect for outcomes. The model with a common treatment effect is
identical to Equation (11) except in the second model we estimate a common time×treatment
interaction (underlined):

(15)
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The common time × treatment is constructed by multiplying the time variable and the
treatment indicator irrespective of outcome type. This is in contrast to Equation (11) where
the time × treatment interaction is multiplied by the outcome variable indicators so that
unique treatment effects can be estimate for each outcome. The null hypothesis for the
likelihood ratio test is that there is no difference in model fit between the model with a
common time×treatment interaction—Equation (15)—and the model with unique
time×treatment interactions—Equation (11).4 In our example, the likelihood ratio test was
significant, χ2(1)=9.43, p<.01, indicating that the model with unique treatment effects for
outcome types fit the data better than the model with a common treatment effect.
The third method for testing for differential treatment effects is to add a three-way
interaction between time, treatment, and either dj or qj to Equation (15):

(16)
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It does not matter whether we use dj or qj; however, because we used dj then β3 is
interpreted as the time×treatment interaction for quality of life and β4 is difference between
the time×treatment interaction for depression and the time×treatment interaction for quality
of life. Thus, the null hypothesis for β4 is that there is no difference between the
time×treatment interaction across outcomes—that is, the treatment effect does not differ
with respect to outcome. The significance test for β4 is identical to the post-analysis contrast
of the difference between β13 and β23 from Equation (11).
Suppose that none of the tests of the differential treatment effect was significant. This would
indicate that the outcomes share a common treatment effect. In that case, the model in
Equation (15), which estimates a common treatment effect across outcomes, could be used
in place of the model in Equation (11), which estimates unique treatment effects. Note that
this simplification is justified because we formally tested whether the coefficients differed.

4Because Equations (11) and (15) differ with respect to the fixed effects, the likelihood ratio test can only be used if maximum
likelihood rather than restricted maximum likelihood estimation was used (see Singer & Willet, 2003, for an introductory disscussion
of likelihood ratio tests).
J Consult Clin Psychol. Author manuscript; available in PMC 2015 October 01.
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Simply evaluating the significance of the coefficients in Equation (11) does not provide a
basis for estimating a common effect.
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Although we have focused on using these tests to evaluate differential treatment effects
across outcomes, the three methods we described can be used to test whether any fixed
effect differs across outcomes. For example, in a psychopathology study, we could use these
methods to evaluate whether the average growth in one variable differs from the average
growth in a second variable. Furthermore, these tests can be extended to more than two
outcomes in which once can test whether all effects are equal.
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In order for the tests of differential treatment effects, or any test of differences between fixed
effects, to be interpretable, it is essential that the outcome variables be on the same metric as
they were in our example. Recall that the null hypothesis for the differential treatment effect
is that β13 − β23=0. The scale of β13 and β23 are dictated by the scale of the outcome
variable. If depression and quality of life are on different metrics then the difference
between the coefficients may be non-zero as function of the metrics rather than a real
difference. Consequently, the difference will be difficult, if not impossible, to interpret and
the hypothesis test incorrect. This is precisely the same problem faced in meta-analysis. In a
meta-analysis of randomized trials we aim to compare treatment effects across different
measures with different scales. To solve this problem we standardize the treatment effects
using effect sizes. In treatment meta-analyses, we often use Cohen’s d, which expresses
mean differences in terms of standard deviation units. We recommend a similar strategy for
multivariate models where the outcome variables are on different metrics and where the aim
of the analysis is to test differences in fixed effects across outcomes. The standardization
could take several forms but a reasonable choice would be to create z-scores using the mean
and standard deviation from all time points.

Examining the Relationship Between Outcomes
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Up to this point we have used the multivariate multilevel model to examine whether the
relationship between a predictor variable (e.g., treatment condition) and the outcome
variable differed across outcomes type (e.g., depression versus quality of life)—that is, we
compared the fixed effects across outcomes. We can also use the multivariate model to
examine the relationship between the outcomes. Suvak et al. (2009) used multivariate
multilevel models to explore the relationship between intrusion and avoidance over time in a
sample of trauma survivors. For example, they examined the correlation between rate of
change in intrusion symptoms and avoidance symptoms (i.e., the correlation between the
random slopes) as well as the correlation between initial intrusion symptoms and rate of
change in avoidance symptoms (i.e., the correlation between the random intercept and
random slope) and vice versa.
In our example data, we considered the two categories of correlations used by Suvak et al.
(2009). The first category of correlation is to examine the relationship between similar
parameters across outcomes. We can examine the relationship between the random
intercepts from each outcome to assess how the person-specific baseline values are related.
Likewise, we can examine the relationship between the random slopes from each outcome to
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assess how the person-specific rates of change are related. The formulae for the correlation
between intercepts, rI, and slopes, rS, are (Fieuws & Verbeke, 2004):
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(17)

(18)
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Each of the components in Equations (17) and (18) are drawn from the covariance matrix of
the multivariate related outcomes model described in Equation (9) and displayed in Table 2.
Thus, the numerator of Equation (17) is the covariance between the random intercepts and
the denominator is the product of the square root of the variance of the intercepts. Equation
(18) is identical except it involves the variances and covariance of the random slopes. The
correlation among the intercepts was rI =.26,5 indicating a small positive relationship
between the person-specific baseline values of depression and quality of life. The correlation
among the slopes was rS =.76, indicating a strong positive relationship between the personspecific rates of change for depression and quality of life.
Power can be a significant challenge when estimating the relationship between slopes.
Hertzog, Lindenberger, Ghisletta, and von Oertzen (2006) showed that power to detect
relationships among slopes can be low even with large samples and several measurement
occasions.6 A key factor in determining power is what they called Growth Curve Reliability,
which can be defined as the proportion of the total variability in an outcome that is
accounted for by person-to-person variability in intercepts and slopes. If the reliability is
low, power for examining the relationship between slopes will typically be low, even when
sample sizes are large. Researchers wishing to examine relationships between outcomes will
need to consider these issues when designing their studies and interpreting the results of the
multivariate models.
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The second category of correlation is to examine the relationship between distinct
parameters across outcomes. Substantively, we might consider whether baseline quality of
life affects the rate of change in depression symptoms. The formula for the correlation
between the random intercepts for quality of life and the rate of change for depression is:
(19)

5Standard errors for this correlation, as well as the others described in this section, can be obtained using the delta method (Fieuws &
Verbeke, 2004). Stata and Mplus will provide standard errors based on the delta method. However, the delta method assumes the
sampling distribution of these correlations is normally distributed, which it is not. Consequently, the delta method can produce
problematic results, such as confidence intervals that exceed the boundary of a correlation. Alternatives include fitting a model with a
covariance a model with the covariance constrained to zero and using a likelihood ratio test to compare the fit. Additionally,
bootstrapping the confidence intervals can be helpful. Finally, Bayesian methods provide a useful alternative for interval estimation
for correlations (Baldwin & Fellingham, 2012).
6We thank an anonymous reviewer for pointing us toward this reference.
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The formula the correlation between the random intercepts for depression and the rate of
change for quality of life has the same form but uses the appropriate parameters. There was
a small negative correlation between baseline values for quality of life and rate of change in
depression, rIS = −.23. The correlation between baseline values in depression and rate of
change in quality of life was also small and negative, rIS = −.16. Thus, there was little
relationship between a participant’s baseline standing on one outcome and the rate of change
on the other outcome.

Extending the Model to Three or More Outcomes
The multivariate model can be extended to three or more outcomes by adding fixed and
random effects for the third outcome. For example, suppose in addition to depression and
quality of life we also measured anxiety symptoms. To Equations (1) and (2) we would add
the following equation:
(20)
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where the parameters have the same interpretation as before except the pertain to anxiety. In
order to accommodate the model with three outcomes in software that expects the data in
long format, we would again use indicator variables to identify which parameters go with
particular outcomes. In this case, we create three indicator variables, dj, qj, and a j, where dj
= 1 for depression and 0 for the others, qj = 1 for quality of life and 0 for the others, aj = 1
for anxiety and 0 for the others. As previously, we use the indicator variables to create a
single equation:

(21)

The variance/covariance matrices for the random effects and the residuals are also extended.
The random effects matrix includes all six random effects:
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(22)

The residual matrix includes all three residuals:

(23)
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For both matrices the interpretation of the parameters is the same as discussed previously
except now the matrices include additional variances and covariances involving the third
outcome.
The types of question we can examine with three or more outcomes are similar to the model
with two outcomes. We can compute the correlations among the random effects. Likewise,
we can compare whether treatment effects differ across the three outcomes or whether the
treatment effect on depression differs from the average of the other outcomes. As before,
scaling of the outcome variables needs to be identical for the comparisons to be meaningful.
We can also estimate a joint test of whether all three treatment effects are zero using a postanalysis contrast. However, the simplest way is to use a likelihood ratio test that compares
the fit of the model in Equation (21) to a model that is identical to Equation (21) except that
it excludes all time × treatment effects (i.e., fixes all treatment effects to zero).
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The model with three outcomes is considerably more complex than even the model with two
outcomes. For example, the model with three outcomes involves 39 parameters and the
model with two outcomes involves 21 parameters. It can be challenging to ensure that the
more complicated model is correctly specified in software programs as there are many
variables and interactions in both the fixed and random effects portions of the model.
Furthermore, most multilevel software was not explicitly designed to model multivariate
data in this way. Consequently, estimation can be slow, especially with large datasets.
Multilevel software that is multivariate in nature, such as Mplus, typically does not have
much trouble estimating these models, even with large datasets.

Extensions
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In the present paper, we detailed how to use multivariate multilevel models to examine the
relationship between multiple outcomes in a clinical trial. However, this is one of many
possible applications of multivariate models that psychotherapy researchers might use. For
example, models for dyadic psychotherapy data can be framed as a multivariate model.
Suppose one had collected martial satisfaction data three times for 100 couples. One way to
model this data is to use a 3-level multilevel model, with observations at level-1, participant
at level-2, and dyad at level-3. Alternatively, we could use a 2-level multivariate model with
two outcomes, one for each partner (Atkins, 2005, describes the benefits and drawbacks for
both 2- and 3-level models). This multivariate model is similar to our differential treatment
effects examples, except we would exchange the primary and secondary outcomes with the
partners’ outcomes. The actor-partner interdependence model for dyadic data can also be
estimated using a multivariate multilevel model (Kenny, Kashy, & Cook, 2006).
Multivariate multilevel models can be used in social relations modeling (Kenny, 1994;
Kenny et al., 2006) approaches to psychotherapy data. For example, Marcus, Kashy, and
Baldwin (2009) used a multivariate multilevel model to apply a social relations model to
therapeutic alliance data (see also Marcus, Kashy, Wintersteen, & Diamond, 2011). In this
study, patients and therapists each rated the alliance. The primary question was whether
therapists and clients agree with respect to their alliance ratings. That is, if a therapist
consistently rates her alliances as high across her caseload, do her patients also rate the
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alliance high across her caseload—the correlation among the patient and therapist alliance
ratings at the therapist-level. Additionally, they examined whether therapists and patients
agree within caseloads—the correlation among the patient and therapist ratings at the
patient-level (see also Imel, Hubbard, Rutter, & Simon, 2013).
Other examples of multivariate multilevel models relevant to psychotherapy data include
using them: (a) to examine mediation hypotheses in a multilevel context (Bauer, Preacher, &
Gil, 2006), in which both the dependent variable and the mediator(s) are included as
outcomes in the multilevel model; (b) to fit measurement models where item responses are
included as outcomes in the multilevel model (Zheng & Rabe-Hesketh, 2007); (c) to fit
multivariate meta-analyses where two or more effect sizes from a single study are analyzed
simultaneously (Riley, Abrams, Sutton, Lambert, & Thompson, 2007; White, 2011); (d) to
examine the relationship between outcomes with different distributional forms (e.g.,
comparing a normally distributed outcome to a binary outcome; Hadfield, 2010); and (e) to
simultaneously examine predictors unique to each outcome or different functional forms for
change across outcomes (e.g., linear change for one outcome and quadratic change for
another; MacCallum et al., 1997).

NIH-PA Author Manuscript

Another extension to the models we have presented is to estimate them from a structural
equation modeling perspective or from a perspective that combines multilevel modeling and
structural equation modeling.7 For example, Bollen and Curran (2006) discuss a multivariate
latent growth curve model similar to our example but where one estimates regression paths
between the random intercepts and slopes, rather than covariances only. For example, in an
alcohol treatment study, if we hypothesized that variability among patients in depressive
symptoms prior to treatment (i.e., random intercept for depression) would predict variability
in the rate of change in drinking behavior (i.e., random slope for drinking behavior), we
could estimate the regression path between the random intercept for depression and random
slope for drinking behavior.
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Mehta and Neale (2005) also illustrate how multilevel factor analysis is an extension of the
multivariate multilevel models. They fit a multilevel factor analysis model to literacy data
that included five measures of literacy taken on students clustered within schools. They fit a
multilevel model with random intercepts for each of the schools. Rather than estimating
correlations among the random intercepts and residuals, they estimated a common factor at
both the school-level (i.e., random intercept) and student-level (i.e., residual). To be sure,
fitting such a model is challenging and may require more data than is typically available to
psychotherapy researchers. Nevertheless, Mehta and Neale’s (2005) example provides an
additional illustration of how we could extend the models discussed in this paper. Other
interesting methodological developments are likely to occur at the intersection of multilevel
modeling and structural equation modeling.

7The intersection between structural equation modeling and multilevel models has been discussed at length (e.g., Bauer, 2003; Curran,
2003; Skrondal & Rabe-Hesketh, 2004), with a number of writers illustrating how one can parameterize structural equation models to
reproduce a multilevel model (Bauer, 2003; Curran, 2003; Mehta & Neale, 2005). Theoretical work has been done to frame multilevel
models and structural equation models as special cases of a broader class of models known as generalized latent variable models
(Skrondal & Rabe-Hesketh, 2004). In fact, the notion that multilevel models and structural equation models are both latent variable
models is a foundational idea for some software programs including gllamm (which stands for Generalized Linear Latent and Mixed
Models) in Stata (Rabe-Hesketh, Skrondal, & Pickles, 2002) and Mplus (Muthén & Muthén, 2012).
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Conclusion
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We introduced the multivariate multilevel model as a way to examine hypotheses that are
important to psychotherapy research. As with any methodology, advances in psychotherapy
research are not going to take place simply because we apply multivariate multilevel models
to our data. However, many, if not most, theories about how and why psychotherapy works
are multivariate in nature. As we have shown, these multivariate hypotheses can be
addressed with a multivariate multilevel model in ways that are not possible with univariate
models. We suspect as more researchers become familiar with these techniques we will see
more creative uses of multivariate models that improve our understanding of psychotherapy.
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Wide and Long Datasets for Multivariate Multilevel Data.
Wide
ID

Time

Depression

Quality of Life

1

0

−1.37

−0.58

1

1

−1.31

0.24

1

2

−0.52

0.01

2

0

0.05

2.00

2

1

−0.84

1.83

2

2

−1.86

0.31
Long
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ID

Time

Y

Depression

Quality of Life

1

0

−1.37

1

0

1

1

−1.31

1

0

1

2

−0.52

1

0

1

0

−0.58

0

1

1

1

0.24

0

1

1

2

0.01

0

1

2

0

0.05

1

0

2

1

−0.84

1

0

2

2

−1.86

1

0

2

0

2.00

0

1

2

1

1.83

0

1

2

2

0.31

0

1
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.06 (.07)
.16 (.18)
−.41* (.10)

β12
β13

Treatment

Time × Treatment

---

β22
β23

Treatment

Time × Treatment
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σu2v2

-----

σu1u2
σu1v2
σv1u2
σv1v2

cov(u1j,u2j)

cov(u1j,v2j)

cov(v1j,u2j)

cov(v1j,v2j)

Between Outcomes

--

--

v2j

cov(u2j,v2j)

--

u2j

Quality of Life

.004

.04

v1j

cov(u1j,v1j)

.49

u1j

σu1v1

--

β21

Time

Depression

--

β20

Intercept

Quality of Life

−.08 (.13)

β10
β11

Time

Depression

Intercept

Depression

Parameter

--

--

--

--

−.14

.14

.73

--

--

--

−.09 (.14)

.08 (.20)

.002 (.08)

−.08 (.14)

--

--

--

--

Quality of Life

Univariate

--

--

--

--

−.14

.14

.73

.004

.04

.49

−.09 (.14)

.08 (.20)

.002 (.08)

−.08 (.14)

−.41* (.10)

.16 (.18)

.06 (.07)

−.08 (.13)

Independent Outcomes

.06

−.04

−.04

.16

−.14

.14

.73

.004

.04

.49

−.09 (.14)

.08 (.20)

.002 (.08)

−.08 (.14)

−.41* (.10)

.16 (.18)

.06 (.07)

−.08 (.13)

Related Outcomes

Multivariate

Results of Univariate and Multivariate Models for Depression and Quality of Life Outcomes.
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Deviance

p < .05

Note.

*

σe1e2
752.268

--

--

e2ij

cov(e 1ij,e2ij)

.39

e 1ij

Residuals

Depression
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Parameter

749.363

--

.30

--

Quality of Life
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1501.631

--

.30

.39

Independent Outcomes

1444.798

.15

.30

.39

Related Outcomes

Multivariate
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Univariate
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